CHTRX | VITSX | CHTRX / VITSX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 56 years | 27 years | - |
Gain YTD | 25.501 | 22.419 | 114% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.57B | 1.73T | 0% |
Annual Yield % from dividends | 0.31 | 1.36 | 23% |
Returns for 1 year | 24.83 | 30.53 | 81% |
Returns for 3 years | -4.45 | 19.92 | -22% |
Returns for 5 years | 20.37 | 83.73 | 24% |
Returns for 10 years | -5.11 | 186.74 | -3% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MSRDX | 4.57 | N/A | N/A |
Morgan Stanley Inst Global Real Est C | |||
MPITX | 14.06 | -0.08 | -0.57% |
BNY Mellon International M | |||
TASMX | 32.03 | -0.27 | -0.84% |
Transamerica Small/Mid Cap Value R6 | |||
CIVCX | 16.55 | -0.15 | -0.90% |
American Funds International Vntg 529-E | |||
PASTX | 53.06 | -1.09 | -2.01% |
T. Rowe Price Science & Tech Adv |